Literature DB >> 26658918

A Side by Side Comparison of Bruker Biotyper and VITEK MS: Utility of MALDI-TOF MS Technology for Microorganism Identification in a Public Health Reference Laboratory.

Simon Lévesque1, Philippe J Dufresne1, Hafid Soualhine1, Marc-Christian Domingo1, Sadjia Bekal1,2, Brigitte Lefebvre1, Cécile Tremblay1,3.   

Abstract

Matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS) has emerged as a rapid, highly accurate, and cost-effective method for routine identification of a wide range of microorganisms. We carried out a side by side comparative evaluation of the performance of Bruker Biotyper versus VITEK MS for identification of a large and diverse collection of microorganisms. Most difficult and/or unusual microorganisms, as well as commonly encountered microorganisms were selected, including Gram-positive and negative bacteria, mycobacteria, actinomycetes, yeasts and filamentous fungi. Six hundred forty two strains representing 159 genera and 441 species from clinical specimens previously identified at the Laboratoire de santé publique du Québec (LSPQ) by reference methods were retrospectively chosen for the study. They included 254 Gram-positive bacteria, 167 Gram-negative bacteria, 109 mycobacteria and aerobic actinomycetes and 112 yeasts and moulds. MALDI-TOF MS analyses were performed on both systems according to the manufacturer's instructions. Of the 642 strains tested, the name of the genus and / or species of 572 strains were referenced in the Bruker database while 406 were present in the VITEK MS IVD database. The Biotyper correctly identified 494 (86.4%) of the strains, while the VITEK MS correctly identified 362 (92.3%) of the strains (excluding 14 mycobacteria that were not tested). Of the 70 strains not present in the Bruker database at the species level, the Biotyper correctly identified 10 (14.3%) to the genus level and 2 (2.9%) to the complex/group level. For 52 (74.2%) strains, we obtained no identification, and an incorrect identification was given for 6 (8.6%) strains. Of the 178 strains not present in the VITEK MS IVD database at the species level (excluding 71 untested mycobacteria and actinomycetes), the VITEK MS correctly identified 12 (6.8%) of the strains each to the genus and to the complex/group level. For 97 (54.5%) strains, no identification was given and for 69 (38.7%) strains, an incorrect identification was obtained. Our study demonstrates that both systems gave a high level (above 85%) of correct identification for a wide range of microorganisms. However, VITEK MS gave more misidentification when the microorganism analysed was not present in the database, compared to Bruker Biotyper. This should be taken into account when this technology is used alone for microorganism identification in a public health laboratory, where isolates received are often difficult to identify and/or unusual microorganisms.

Entities:  

Mesh:

Year:  2015        PMID: 26658918      PMCID: PMC4689555          DOI: 10.1371/journal.pone.0144878

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


Introduction

Identification of microorganisms in a clinical microbiology laboratory provides definitive knowledge about the cause of infection and plays a critical role in patient management and choice of antimicrobial treatment. Traditionally, the identification of bacteria and fungi in clinical laboratories has relied on phenotypic methods, such as growth on selective and non-selective media, morphology of colonies, Gram-stain, microscopic morphology and typical biochemical reactions, using multiple automated and/or manual testing methods [1]. These methods are laborious, time consuming and require a relatively long turn-around time. In addition, unusual and difficult-to-identify organisms encountered in the clinical laboratory may need to be sent to a reference laboratory for ultimate identification, often obtained by DNA sequencing. Matrix-assisted laser desorption ionization–time of flight mass spectrometry (MALDI-TOF MS) has emerged as a rapid, highly accurate, and cost-effective method for routine identification of a wide range of microorganisms [2,3]. The technology is now widespread, as readily evidenced by the ever increasing number of publications describing the use of this method for identifying clinical isolates of microorganisms [4]. In North America, there are two commercially available MALDI-TOF MS systems for microbial identification, the Bruker Biotyper (Bruker Daltonics) and the VITEK MSTM PLUS (bioMérieux) (hereinafter named VITEK MS). A small number of studies have simultaneously evaluated the performance of multiple MALDI-TOF MS systems and found them comparable for the identification of a variety of aerobic and anaerobic bacteria and yeast [5]. The majority of MALDI-TOF MS evaluation study designs target the identification of common microorganisms routinely identified in clinical laboratories. To our knowledge, only one study has evaluated the accuracy of both VITEK MS and Bruker Biotyper for the identification of the most difficult and/or unusual microorganisms [6]. The authors found no significant difference in the number of organisms identified to the genus level, species level, unidentified or misidentified by the two MALDI-TOF MS systems. Despite having evaluated an extensive clinical collection of microorganisms the most difficult and/or unusual microorganisms, the vast majority of genus and species were present in both software databases, except for filamentous fungi. In the current study, we carried out a side by side comparative evaluation of the performance of Bruker Biotyper versus VITEK MS for identification of a large and diverse collection of microorganisms. Most difficult to identify and/or unusual microorganisms, as well as commonly encountered microorganisms were selected, including Gram-positive and -negative bacteria, mycobacteria, actinomycetes, yeasts and filamentous fungi. The first objective of our study was to evaluate the performance of microorganism identification of both systems in comparison with methods used in a Public Health Reference Laboratory. The second objective was to evaluate the response of both systems for the identification of microorganisms which are not present in the software database.

Materials and Methods

Source and Type of Microorganisms Tested

The Laboratoire de santé publique du Québec (LSPQ) is the reference microbiology laboratory for the identification of microorganisms received from clinical laboratories in the province of Quebec. Microorganism identification is part of the mandate of the LSPQ, so no ethical approval was needed for this study. Six hundred forty two strains representing 159 genera and 441 species from clinical specimens previously identified at the LSPQ were retrospectively chosen for the study. They include 254 Gram-positive bacteria, 167 Gram-negative bacteria, 109 mycobacteria and aerobic actinomycetes and 112 yeasts and mould. All microorganisms were previously identified according to LSPQ reference methods: 16S rRNA [7] or tuf gene sequencing for Gram-positive bacteria, 16S rRNA, rpoB [8] or cpn60 gene [9] sequencing for Gram-negative bacteria, conventional biochemical testing for Enterobacteriaceae [10], 16S rRNA or hsp65 gene sequencing [11] for mycobacteria and actinomycetes and ribosomal DNA (ITS / D1D2 regions) [12,13] or beta tubulin gene (benA) [14,15] sequencing for yeast and fungi. All microorganisms were identified at the LSPQ from 2009 to 2013. Strains were stored at -80°C and subcultured on the appropriate culture media to obtain sufficient growth.

MALDI-TOF MS Identification with Bruker Biotyper

Depending on the microorganism, different identification protocols were used according to the manufacturer’s instructions. For bacteria and yeasts up to three different extraction procedures were used. The “direct colony extraction technique” by which the microbes are directly applied as a thin film on a spot of the target slide (a reusable 96 wells stainless steel target slide, Bruker Daltonics), allowed to dry at room temperature, followed by the addition of 1 μl of HCCA matrix onto each sample spot dried at room temperature prior to MS analysis. The “on slide formic acid extraction” technique consisted of the addition of 1 μl of 70% formic acid directly onto the dried bacterial or yeast spot that was dried once more prior to adding the HCCA matrix. The “in tube formic acid extraction” technique was performed by adding one or two colonies to a microcentrifuge tube containing 300 μl of HPLC grade deionized water. The suspension was mixed thoroughly by pipetting, and 900 μl of absolute ethanol was further added and mixed thoroughly again. After a centrifugation of 2 minutes at 13 000 rpm, the supernatant was discarded and 50 μl of 70% formic acid was added to the pellet and vortexed. Fifty μl of 100% acetonitrile was added and mixed, followed by a 2 minute centrifugation at 13 000 rpm. One μl of the supernatant was added to the target slide and dried at room temperature. One μl of the HCCA matrix was applied on the sample spot and dried at room temperature. For mycobacteria and aerobic actinomycetes, the inactivation extraction method was performed as follows. A loopful of microorganisms from a solid culture medium (Middelbrook 7H10 for mycobacteria and Sabouraud agar for aerobic actinomycetes) was added to 300 μl of HPLC grade deionized water into an Eppendorf tube. The solution was inactivated by heat for 30 minutes at 100°C. After a centrifugation of 2 minutes at 13 000 rpm, the supernatant was discarded and 300 μl of HPLC grade deionized water was added. Then, 900 μl of absolute ethanol was added and vortexed thoroughly. After centrifugation of 2 minutes at 13 000 rpm, the supernatant was discarded and 500 μl of HPLC grade deionized water was added and vortexed in order to completely suspend the pellet. After centrifugation of 2 minutes at 13 000 rpm, the supernatant was discarded and 50 μl of HPLC grade deionized water was added and vortexed. The solution was heated for 10 minutes at 95°C. Once the solution had cooled down, 1200 μl of pre-cooled (-20°C) absolute ethanol was added. Since the previous steps were performed in a containment level 3 laboratory, viability tests for the Mycobacterium tuberculosis (MTB) complex isolates were assessed by plating the crude extract to ensure the cells had all been inactivated before proceeding to MS identification. The extracts were stored at (-20°C) during 6 weeks required for the completion of the viability tests. Once confirmed as inactivated, the extracts were centrifuged for 2 minutes at 13 000 rpm, the supernatant was discarded and the pellet was completely air dried. Fifty μl of 100% acetonitrile and 0.5 mm Zirconia / Silica beads (BioSpec Products) were added and vortexed at maximum speed for 1 minute. The extract was supplemented with 50 μl of 70% formic acid and vortexed for 5 seconds. The suspension was centrifuged for 2 minutes at 13 000 rpm. One μl of the supernatant was added to the target slide and dried at room temperature. One μl of the HCCA matrix was applied on the sample spot and dried at room temperature. For moulds, the cultivation procedure was performed as follows. From sufficient growth on a Sabouraud agar plate, a Sabouraud liquid media tube was inoculated with a few well isolated colonies and closed tightly. Tubes were placed into a rotator to shake over head. After 24–48h of growth in the rotator, the tube was placed in a standing rack for 10 minutes to let the fungal culture settle at the bottom of the tube. Then, 1.5 ml of sedimented fraction was harvested and transferred into an Eppendorf tube. The tube was centrifuged for 2 minutes at 13 000 rpm and the supernatant discarded. One ml of HPLC grade deionized water was added to the pellet and vortexed for one minute. The tube was centrifuged for 2 minutes at 13 000 rpm and the supernatant was discarded. The pellet was washed one more time with water. The pellet was suspended in 300 μl of HPLC grade deionized water and 900 μl of absolute ethanol, and vortexed. The tube was centrifuged for 2 minutes at 13 000 rpm, the supernatant was discarded and the pellet was allowed to completely dry. Seventy percent formic acid was added proportionally to the size of the pellet. The same amount of 100% acetonitrile was added and mixed. The tube was centrifuged for 2 minutes at 13 000 rpm. One μl of the supernatant was added to the target slide and dried at room temperature. One μl of the HCCA matrix was applied to the sample spot and dried at room temperature. Each microorganism tested was spotted twice on the same target slide. Measurement was performed on a MALDI Biotyper using the manufacturer's suggested settings using automated collecting spectra. Captured spectra were analyzed using MALDI Biotyper automation control and Bruker Biotyper 3.1 software containing the library number 3995. For each run, a standard (bacterial test standard, Bruker Daltonics) was included to calibrate the instrument and validate the run. Identification criteria were used as recommended by the manufacturer: a score of ≥2.000 indicated species level identification, a score between 1.700 and 1.999 indicated identification to the genus level and a score <1.700 was interpreted as no identification. For bacteria, if a good identification was not obtained with the direct colony technique, subsequent deposit was done with the on slide formic acid extraction technique, followed by the in tube formic acid extraction technique.

MALDI-TOF MS Identification with bioMérieux VITEK MS

According to the manufacturer's instructions, different protocols were used depending on the microorganism. For bacteria and yeast, the direct colony technique consisted of applying the microbe as a thin film on a spot of the target slide (disposable 48 wells target slide, bioMérieux) and allowed to visibly dried at room temperature. Subsequently, 1 μl of CHCA matrix was applied on each sample spot and dry at room temperature. The on slide formic acid extraction technique consisted of adding 0.5 μl of 25% formic acid on the bacterial or yeast spot and allowing it to completely dry before the addition of the CHCA matrix. For mycobacteria and actinomycetes, the inactivated method was performed as follows. Two-thirds of a 10 μl calibrated loop of microorganisms from a solid culture media was added to 50 μl of trifluoroacetic acid (Sigma-Aldrich) and vortexed. After 30 minutes at room temperature, 450 μl of HPLC grade deionized water was added to the tube and vortexed. Since the previous steps were performed in a containment level 3 laboratory for the MTB complex, viability testing was performed by plating the solution to ensure that all the cells were inactivated before proceeding to identification. During the viability test, the solution was stored at -20°C. Once inactivation was confirmed, the solution was centrifuged for 2 minutes at 10 000 rpm. One μl of the supernatant was added to the target slide and dried at room temperature. One μl of the CHCA matrix was applied on the sample spot and dried at room temperature. For moulds, the cultivation procedure was performed as follows. From sufficient growth on a Sabouraud dextrose agar plate, a wet swab was used to swab 1 cm2 on the periphery of the plate and suspended in API suspension medium. Nine hundred μl of absolute ethanol was added and vortexed. The tube was then centrifuged for 2 minutes at 10 000 rpm and the supernatant was discarded. Forty μl of 70% formic acid was added to the pellet and vortexed. Forty μl 100% acetonitrile was added and vortexed. The tube was centrifuged for 2 minutes at 10 000 rpm. One μl of the supernatant was added to the target slide and dried at room temperature. One μl of the CHCA matrix was applied on the sample spot and dried at room temperature. Each microorganism tested was deposited twice on the same target slide. Measurement was performed on a VITEK MS using the manufacturer's suggested settings using automated collecting spectra. Captured spectra were analyzed using VITEK MS automation control and Myla software that included IVD database version 2.0. The VITEK MS target slide consists of 48 sample spots divided into three acquisition groups. For each acquisition group, a standard (E. coli ATCC 8739) was included to calibrate the instrument and validate the run. The identification criteria used were those as recommended by the manufacturer: a score of ≥60% indicated species level identification. Obtaining a single genus, regardless of the confidence value, was considered an acceptable genus level of identification. If a split identification containing multiple genera, identification was considered unacceptable and considered unidentified. If no identification was provided, the isolate was considered unidentified. For bacteria, if a good identification was not obtained with the direct colony technique, subsequent deposit was done with the on slide formic acid extraction technique.

Settings of the Study and Discrepancy Analysis

Side by side evaluation was performed on site at the LSPQ from February 2013 to April 2013. Standard training on both MS platforms was provided by manufacturers to the technical team. The same culture plates of each microorganism were used for both systems testing. The same technician performed all the manipulation for bacteria, yeasts and moulds, and a different technician for mycobacteria and actinomycetes. Data were analyzed as follows: LSPQ reference identification was considered as the gold standard. If a discrepancy occurred between Biotyper or VITEK MS and LSPQ identification, MALDI-TOF MS identification was repeated. If a discrepancy occurred between both Biotyper and VITEK and LSPQ identification, LSPQ identification was repeated, according to reference methods mentioned above, only if Biotyper and VITEK MS gave the same results. If there was a discrepancy between the results of the repeated spot on the same technology, only the correct identification (if there was one) was considered. Correct identification was accepted to the species, genus or complex/group level. High score identification (≥2.000 or ≥60%) to a species which was different from the LSPQ identification was considered as wrong identification, even if it was the correct genus. Bad or no spectra acquisition still obtained after one repeat was considered as no identification.

Statistical Analysis

Data were compared by Chi-square test or Bhapkar test [16] with a significance level of p<0.05. Statistical analysis was performed using Statistix version 7.1 (Analytical Software, Tallahassee, FL, USA) and SAS version 9.4 (SAS Canada, Toronto, ON).

Results

Identification when the Microorganism Is Present in the Databases

Of the 642 strains tested, 572 were referenced in the Bruker database while 406 were referenced in the VITEK MS IVD database. Of this number, 14 mycobacteria strains belonging to the MTB complex could not be tested with VITEK MS as we found that the inactivation protocol provided by bioMérieux at the time of the study was not functional and the strains were still viable. Of the 572 strains present in the Bruker database, the Biotyper correctly identified 494 (86.4%) strains: 371 (75.1%) strains to species level, 102 (20.6%) to the genus level and 21 (4.3%) to the complex/group level. For 57 (10%) strains, no identification was obtained and 21 (3.6%) strains were misidentified (Tables 1 and 2, S1 and S2 Tables). Among these incorrect identifications, 15 failed to species level and 6 to genus level (Table 3). Of the 392 strains present in the VITEK MS IVD database (excluding the 14 mycobacteria that were not tested), the VITEK MS correctly identified 362 (92.3%) strains: 319 (88.1%) strains to species level, 33 (9.1%) to the genus level and 10 (2.8%) to the complex/group level. For 20 (5.1%) strains, no identification was obtained and for 10 (2.6%) strains, an incorrect identification was provided (Tables 1 and 4, S1 and S3 Tables). Among these incorrect identifications, there were 3 incorrect identifications to species level and 7 to genus level (Table 3). No statistically significant differences between the two systems were found upon comparison of the identification performance for the 380 strains present in both databases (Bhapkar value of 1.61, p = 0.4470) (Table 1).
Table 1

Identification results when the microorganism is present in both databases.

Reference identificationNumber of isolatesBruker BiotyperVITEK MS (IVD)
Correct identification to the level ofCorrect identification to the level of
SpeciesGenusComplex/groupNo IDMis IDSpeciesGenusComplex/groupNo IDMis ID
Gram-positive cocci1047971332937211
Anaerobes55000050000
Other Gram-positive rods7553123524719342
Enterobacteriaceae17131111151100
Non-fermentative Gram-negative rods42321243323322
Other Gram-negative bacteria66556005640002
Mycobacteriaceae18513000161001
Actinomycetes83203051011
Filamentous fungi1711402071081
Yeast28221041260020
Total number of strains (%) 380 278 (73.2) 47 (12.4) 19 (5) 22 (5.8) 14 (3.6) 310 (81.6) 33 (8.7) 9 (2.4) 18 (4.7) 10 (2.6)

No ID = No identification obtained. Mis ID = Misidentification obtained

Table 2

Identification results when the microorganism is present only in the Bruker Biotyper database.

Reference identificationNumber of isolatesBruker Biotyper
Correct identification to the level of
SpeciesGenusComplex/groupNo IDMis ID
Gram-positive cocci24147003
Anaerobes110000
Other Gram-positive rods33217032
Non-fermentative Gram-negative rods1392011
Other Gram-negative bacteria21191001
Mycobacteriaceae4710252100
Actinomycetes20260120
Filamentous fungi26135080
Total number of strains (%) 192 93 (48.4) 55 (28.7) 2 (1) 35 (18.2) 7 (3.6)

No ID = No identification obtained. Mis ID = Misidentification obtained

Table 3

Misidentification by both systems when the microorganisms is referenced in the database.

Reference identificationProposed ID (confidence value) a
Bruker Biotyper Misidentification to species level Neisseria subflava biovar flava Neisseria flavescens (2.013)
Neisseria subflava biovar flava Neisseria flavescens (2.047)
Neisseria subflava biovar perflava Neisseria flavescens (2.036)
Neisseria subflava biovar subflava Neisseria flavescens (2.129
Neisseria sicca Neisseria mucosa (2.055))
Aeromonas hydrophila Aeromonas caviae (2.356)
Burkholderia cepacia Burkholderia multivorans (2.377)
Pseudomonas pseudoalcaligenes Pseudomonas oleovorans (2.2)
Shewanella algae Shewanella putrefaciens (2.143)
Corynebacterium pseudodiphtheriticum Corynebacterium propinquum(2.303)
Staphylococcus carnosus Staphylococcus condimenti (2.0)
Streptococcus australis Streptococcus parasanguinis (2.028)
Streptococcus australis Streptococcus parasanguinis (2.011)
Streptococcus infantarius Streptococcus lutetiensis (2.021)
Streptococcus infantis Streptococcus peroris (2.0)
Misidentification to genus level Campylobacter hyointestinalis Pandoraea sputorum (2.213)
Rahnella aquatilis Ewingella americana (1.872)
Actinomyces naeslundii Clostridium halophilum (1.828)
Bacillus sp. Corynebacterium tuberculostearicum (2.02)
Microbacterium lacticum Arthrobacter castelli (2.154)
Candida freyschussii Rhodotorula bogoriensis (2.2)
VITEK MS (IVD) Misidentification to species level Neisseria cinerea Neisseria subflava (99.9)
Burkholderia cepacia Burkholderia multivorans (99.9)
Fusarium proliferatum Fusarium oxysporum (97.6)
Misidentification to genus level Campylobacter hyointestinalis Comamonas testosteroni (99.7)
Psychrobacter sp. Eubacterium limosum (99.8)
Corynebacterium sp. Sphingobium xenophagum(99.8)
Microbacterium aurum Paenibacillus durus (86.0)
Staphylococcus hominis Kocuria kristinae (99.9)
Gordonia bronchialis Clavibacter michiganensis (99.8)
Mycobacterium avium Paenibacillus durus (99.9)

aBruker Biotyper confidence value is up to 3.0, and VITEK MS is up to 100.

Table 4

Identification results when the microorganism is present only in the VITEK MS IVD database.

Reference identificationNumber of isolatesVITEK MS (IVD)
Correct identification to the level of
SpeciesGenusComplex/groupNo IDMis ID
Gram-positive cocci1 1
Other Gram-positive rods22
Non- fermentative Gram-negative rods22
Other Gram-negative bacteria11
Mycobacteriaceae11
Filamentous fungi3111
Yeast22
Total number of strains (%) 12 9 (75) 0 1 (8.3) 2 (16.7) 0

No ID = No identification obtained. Mis ID = Misidentification obtained

No ID = No identification obtained. Mis ID = Misidentification obtained No ID = No identification obtained. Mis ID = Misidentification obtained aBruker Biotyper confidence value is up to 3.0, and VITEK MS is up to 100. No ID = No identification obtained. Mis ID = Misidentification obtained For filamentous fungi, only 17 out of 71 strains tested were present in both dataset, but twice as much accounted for in Bruker database with 43 strains compared with 20 strains for VITEK MS IVD database. Overall Biotyper allowed the identification of 50.7% of the strains tested for that group of microorganism, as opposed to only 15.5% for VITEK MS. When present in their respective database, identification with Biotyper system yielded higher percentage of identification (to species, genus or complex) with 76.7% vs 50% correct identification on VITEK MS platform. Only one misidentification on the VITEK MS system (to the species level, see Table 3) was obtained when the filamentous fungus was initially present in the manufacturer’s database, and there was no misidentification for the Biotyper. For yeast, slightly more of the 41 strains tested were present in Bruker database (35 strains) compared to VITEK IVD (30 strains). Overall performance of both systems was similar with 70.7% of yeast correctly identified to species, genus or complex level. That performance increased to 93.3% of correct identification for VITEK MS and to 82.9% for Biotyper when only the strains present in the manufacturer’s database were evaluated.

Identification for Microorganisms Not Present in the Databases

Of the 642 strains tested, 70 were not referenced in the Bruker database at the species level while 249 were not in the VITEK MS IVD database used. Of this number, 71 mycobacteria and actinomycetes strains could not be tested with VITEK MS since the bioMérieux protocol failed to inactivate the strains. Of the 70 strains not present in the Bruker database at the species level, the Biotyper correctly identified 10 (14.3%) to the genus level and 2 (2.9%) to the complex/group level. For 52 (74.2%) strains, we obtained no identification and for 6 (8.6%) strains, an incorrect identification given (Table 5). Among those misidentifications, 2 were incorrect identification to the species level and 4 to the genus level. Of the 178 strains not present in the VITEK MS IVD database at the species level (excluding the 71 untested mycobacteria and actinomycetes), the VITEK MS correctly identified 12 (6.8%) of the strains each to the genus and to the complex/group level. For 97 (54.5%) strains, no identification was given and for 69 (38.7%) strains, an incorrect identification was obtained (Table 6). Among these incorrect identifications, 29 (16.2%) were incorrect identification to species level and 40 (22.5%) to genus level.
Table 5

Identification results when the microorganism is not present in the Bruker Biotyper database.

Reference identificationNumber of isolatesBruker BiotyperProposed IDs (confidence value)
Misidentification to the speciesCorrect ID to the level ofNo IDMis ID
GenusComplex/group
Gram-positive cocci
Arthrobacter soli 11
Desemzia sp.11
Dolosigranulum pigrum 11
Ignavigranum ruoffiae 11
Micrococcus antarcticus 11
Nosocomiicoccus ampullae 11
Vagococcus carniphilus 11
Total 7 0 0 0 7 0
Other Gram-positive rods
Corynebacterium massiliense 11
Corynebacterium pyruviciproducens 11
Microbacterium paraoxydans 22 Microbacterium sp. (2.194)
Microbacterium sp. (2.167)
Terribacillus sp.11
Total 5 0 2 0 3 0
Enterobacteriaceae
Shigella boydii 11 Escherichia coli (2.32)
Shigella dysenteriae 11 Escherichia coli (2.235)
Shigella flexneri 11 Escherichia coli (2.293)
Shigella sonnei 11 Escherichia coli (2.384)
Total 4 0 0 0 0 4
Non-fermentative Gram-negative rods
Vibrio cholerae 22 Vibrio albensis (1.897)
Vibrio albensis (1.837)
Total 2 0 2 0 0 0
Other Gram-negative bacteria
Haemophilus haemolyticus 11
Lautropia mirabilis 11
Total 2 0 0 0 2 0
Mycobacteriaceae
Mycobacterium elephantis 11
Mycobacterium europaeum 11
Mycobacterium goodii 22 Mycobacterium wolinskyi (2.083)
Mycobacterium wolinskyi (2.052)
Mycobacterium kubicae 11
Mycobacterium nebraskense 11
Mycobacterium paraffinicum 11
Mycobacterium parascrofulaceum 321 Mycobacterium avium (1.903)
Mycobacterium scrofulaceum (1.803)
Mycobacterium porcinum 11
Mycobacterium saskatchewanense 11
Mycobacterium scrofulaceum 11
Total 13 2 2 1 8 0
Actinomycetes
Actinomadura sp.11
Nocardia brasiliensis 11 Nocardia sp. (1.755)
Tsukamurella tyrosinosolvense 11 Tsukamurella paurometabola (1,812)
Total 3 0 2 0 1 0
Filamentous fungi
Acremonium strictum 11
Aspergillus calidoustus 11
Aspergillus insuetus 11
Aspergillus melleus 11 Aspergillus ochraceus (1.826)
Aspergillus sclerotiorum 11
Aspergillus sydowii 11 Aspergillus versicolor (1.968)
Cladosporium sphaeospermum 11
Curvularia sp.11
Epicoccum sp.11
Geomyces pannorum 11
Microsporum audouinii 11
Neosartorya sp.11
Penicillium purpurogenum 11
Phialemonium obvatum 11
Phialophora verrucosa 11
Pichia fabianii 11
Pichia rhodanensis 11
Pithomyces sp.11
Purpureocillium lavendulum 11
Pyrenochaeta romeroi 11
Scopulariopsis brumptii 11
Syncephalastrum sp.11
Trichoderma sp.11
Trichophyton mentagrophytes 11
Trichophyton soudanense 11
Trichophyton terrestre 11
Trichophyton verrucosum 11
Trichophyton violaceum 11
Total 28 0 2 1 25 0
Yeast
Candida bracarensis 11
Candida tartarivorans 11
Candida auris 11
Cryptococcus terreus 11
Cryptococcus albidus 11
Lachancea fermentati 11
Total 6 0 0 0 6 0
Total number of strains (%) 70 2 (2.9) 10 (14.3) 2 (2.9) 52 (74.2) 4 (5.7)

No ID = No identification obtained. Mis ID = Misidentification obtained

Table 6

Identification results when the microorganism is not present in the VITEK MS IVD database.

Reference identificationNumber of isolatesVITEK MS (IVD)Proposed IDs (confidence value [%])
Misidentification to the speciesCorrect ID to the level ofNo IDMis ID
GenusComplex/group
Gram-positive cocci
Aerococcus sanguinicola 11 Streptococcus pluranimalium (98.4)
Desemzia sp.11 Corynebacterium jeikeium (95.7)
Dolosigranulum pigrum 11 Paenibacillus peoriae (99,9)
Enterococcus malodoratus 11 Enterococcus avium (99.9)
Enterococcus phoeniculicola 11
Facklamia languida 11
Ignavigranum ruoffiae 11 Shewanella algae (99.9)
Kocuria marina 11 Serratia plymuthica (91.4)
Kocuria rhizophila 11 Kytococcus sedentarius (99.9)
Micrococcus antarcticus 11 Micrococcus luteus/lylae (99.9)
Nosocomiicoccus ampullae 11 Cronobacter malonaticus (87.4)
Rothia aeria 33 Rothia dentocariosa (99.9)
Rothia dentocariosa (99.9)
Rothia dentocariosa (99.9)
Rothia amarae 11
Staphylococcus condimenti 11 Staphylococus carnosus (99.6)
Staphylococcus fleurettii 11
Staphylococcus pettenkoferi 11 Staphylococcus auricularis (92.3)
Streptococcus australis 22
Streptococcus infantis 312 Streptococcus pneumoniae (99.9)
Streptococcus pseudoporcinus 55 Streptococcus porcinus (99.9)
Streptococcus porcinus (99.9)
Streptococcus porcinus (99.9)
Streptococcus porcinus (99.9)
Streptococcus porcinus (98.5)
Vagococcus carniphilus 11 Vagococcus fluvialis (99.9)
Vagococcus lutrae 11
Total 30 14 0 4 5 7
Anaerobes
Flavonifractor plautii 11
Total 1 0 0 0 1 0
Other Gram-positive rods
Actinobaculum schaalii 22 Actinomyces meyeri (99.7)
Yersinia enterocolitica (99.8)
Actinobaculum urinale 11 Streptococcus pseudopneumoniae (98.9)
Actinomyces canis 11 Micrococcus luteus/lylae (97.6)
Actinomyces graevenitzii 22
Actinomyces naeslundii 22 Actinomyces viscosus (99.9)
Actinomyces viscosus (99.9)
Actinomyces urogenitalis 11
Atopobium rimae 11 Clostridium butyricum (99.9)
Bacillus flexus 11 Bacillus megaterium (99.7)
Bacillus halodurans 11
Bacillus idriensis 11
Bacillus nealsonii 11
Bacillus siralis 11
Corynebacterium accolens 11
Corynebacterium afermentans 11
Corynebacterium durum 11
Corynebacterium massiliense 11 Corynebacterium tuberculostearicum (99.9)
Corynebacterium minutissimum 321 Corynebacterium aurimucosum (99.9)
Corynebacterium aurimucosum (99.9)
Corynebacterium pyruviciproducens 11
Corynebacterium riegelii 11 Burkholderia gladioli (79.2)
Curtobacterium sp.11 Actinomyces meyeri (99.9)
Lactobacillus kalixensis 11
Lactobacillus reuteri 11
Paenibacillus taiwanensis 11 Paenibacillus sp. (99.9)
Propionimicrobium lymphophilum 11 Staphylococcus carnosus ssp carnosus (99.9)
Microbacterium lacticum 211 Paenibacillus durus (99.9)
Microbacterium oleivorans 11
Sporosarcina sp.11
Terribacillus sp.11
Turicella otitidis 22
Total 36 6 1 0 20 9
Enterobacteriaceae
Shigella boydii 11 Escherichia coli (99.9)
Shigella dysenteriae 11 Escherichia coli (99.9)
Shigella flexneri 11 Escherichia coli (99.9)
Shigella sonnei 11 Escherichia coli (99.9)
Total 4 0 0 0 0 4
Non-fermentative Gram-negative rods
Acidovorax temperans 11
Burkholderia thailandensis 11 Burkholderia cepacia (50.7)
Burkholderia tropica 11 Yersinia ruckeri (99.9)
Capnocytophaga canimorsus 11
Cupriavidus respiraculi 11 Cupriavidus pauculus (96.8)
Cupriavidus metallidurans 11 Cupriavidus pauculus (99.9)
Lautropia mirabilis 11 Haemophilus parainfluenzae (99.7)
Leptotrichia trevisanii 11 Leptotrichia buccalis (99.9)
Massilia timonae 11
Pandoraea apista 11
Pandoraea sputorum 11
Pseudomonas pseudoalcaligenes 11 Pseudomonas oleovorans (99.9)
Roseomonas mucosa 211 Staphylococcus intermedius (99.6)
Total 14 4 1 0 6 3
Other Gram-negative bacteria
Arcobacter butzleri 22
Bordetella holmesii 11
Helicobacter cinaedi 11 Vibrio mimicus (99.9)
Legionella anisa 33
Legionella bozemanae 211 Legionella pneumophila (65.7)
Legionella dumoffii 11
Legionella jordanis 11
Legionella longbeachae 22
Legionella micdadei 22
Legionella rubrilucens 11
Moraxella atlantae 11 Eikenella corrodens (78.4)
Neisseria sicca 11 Neisseria mucosa (99.9)
Neisseria weaveri 11 Neisseria zoodegmatis (99.9)
Pasteurella bettyae 11
Pasteurella dagmatis 11
Total 21 2 1 0 15 3
Mycobacteriaceae
Mycobacterium conceptionense 11
Mycobacterium florentinum 11 Mycobacterium tuberculosis (50.0),
Mycobacterium bovis (50.0)
Mycobacterium gordonae 11 Mycobacterium tuberculosis (50.0),
Mycobacterium bovis (50.0)
Mycobacterium interjectum 11 Mycobacterium tuberculosis (50.0),
Mycobacterium bovis (50.0)
Mycobacterium kumamotonense 11
Mycobacterium marinum 11 Mycobacterium kansasii (86.5)
Mycobacterium peregrinum 11 Mycobacterium fortuitum (99.9)
Mycobacterium porcinum 11
Mycobacterium saskatchewanense 11 Staphylococcus vitulinus (95.8)
Total 9 2 3 0 3 1
Actinomycetes
Nocardia brasiliensis 11
Tsukamurella tyrosinosolvense 11
Total 2 0 0 0 2 0
Filamentous fungi
Acremonium strictum 11
Arthrographis kalrae 11
Aspergillus glaucus 11
Aspergillus insuetus 11
Aspergillus melleus 11
Aspergillus sclerotiorum 11 Candida kefyr (84.8)
Aspergillus terreus 11
Aureobasidium pullulans 11
Chaetomium globosum 11
Chrysosporium sp.22 Candida famata (99.9)
Candida norvegensis (99.2)
Cladosporium sphaeospermum 11
Curvularia sp.11
Epicoccum sp.11 Paecilomyces lilacinus (99.8)
Epidermophyton floccosum 11
Exophiala dermatitidis 11
Geomyces pannorum 11 Candida krusei (97.1)
Lichtheimia corymbifera 11
Microsporum audouinii 11
Microsporum canis 11
Microsporum gypseum 11
Microsporum persicolor 11 Candida kefyr (85.1)
Mucor sp.11
Neosartorya sp.11
Phialemonium obvatum 11
Phialophora verrucosa 11
Phoma sp.11 Candida dubliniensis (84.5)
Pichia fabianii 11
Pichia rhodanensis 11 Candida freyschussii (99.9)
Pithomyces sp.11
Pseudallescheria boydii 11
Purpureocillium lavendulum 11
Pyrenochaeta romeroi 11
Rhizomucor pusillus 11
Rhizopus stolonifer 11 Malassezia pachydermatis (99.8)
Scedosporium apiospermum 22
Scedosporium prolificans 11 Williopsis saturnus (96.2)
Scopulariopsis brevicaulis 11
Scopulariopsis brumptii 11
Syncephalastrum sp.11
Trichoderma sp.11
Trichophyton interdigitale 11 Candida norvegica (98.2)
Trichophyton mentagrophytes 11
Trichophyton rubrum 22
Trichophyton soudanense 11
Trichophyton terrestre 11
Trichophyton tonsurans 11
Trichophyton verrucosum 11 Candida tropicalis (92.8)
Trichophyton violaceum 11
Total 51 0 0 1 38 12
Yeast
Candida bracarensis 11 Zygosaccharomyces bailii (99.7)
Candida nivariensis 11
Candida orthopsilosis 11
Candida pararugosa 11
Candida tartarivorans 11
Candida auris 11
Candida palmioleophila 11
Cryptococcus gattii 11
Pseudozyma sp.11
Trichosporon cutaneum 11 Trichosporon mucoides (99.8)
Total 10 1 0 1 7 1
Total number of strains (%) 178 29 (16.2) 6 (3.4) 6 (3.4) 97 (54.5) 40 (22.5)

No ID = No identification obtained. Mis ID = Misidentification obtained

No ID = No identification obtained. Mis ID = Misidentification obtained No ID = No identification obtained. Mis ID = Misidentification obtained For yeasts, a few of the strains tested were absent of the VITEK MS IVD database and Bruker database with 6 and 11 strains, respectively. The difference was even more pronounced for filamentous fungi with 51 strains not present in VITEK MS IVD compared to 28 for Bruker database. When filamentous fungi was absent from database, 12 misidentifications, mainly to genus, were recorded on the VITEK MS compared to none with Biotyper. Misidentification for yeast species occurred only twice with VITEK MS vs none with Biotyper.

Impact of Protocols on Identification Performance

More than one extraction protocol can be used for bacterial identification. Among the bacteria analysed with each MALDI-TOF MS platform, a correct identification was obtained with the Bruker Biotyper for 199 out of the 364 bacteria tested (54.7%) with the direct colony protocol compared to 263 out of the 304 bacteria tested (86.5%) with the VITEK MS (p<0.0001). With the Bruker Biotyper, 98 identifications (26.9%) were obtained with the “on slide formic acid” extraction protocol. Then, 67 identifications (18.4%) were obtained with the “in tube formic acid” extraction protocol as the on slide acid formic protocol failed to provide suitable results (Table 7). We found that bacteria that needed formic acid extraction were Gram-positive isolates with mucoid or dry textured colonies.
Table 7

Correct identifications obtained for both MALDI-TOF MS technology according to the protocol used for bacteria isolates.

Bruker BiotyperVITEK MS (IVD)
Correct identification to the level ofTotal (%)Correct identification to the level ofTotal (%) p value
SpeciesGenusComplex/groupSpeciesGenusComplex/group
Direct colony179317199 (54.7)241814263 (86.5) p<0.0001
On slide formic acid extraction916198 (26.9)2214541 (13.5)-
In tube formic acid extraction2838167 (18.4)NANANANA-
Total 29847193642632219304-

Discussion

Only a few studies (two in Europe and one in USA) have published side by side evaluations comparing the performance of both systems on an extensive collection of various microorganisms [17-19]. These studies showed more than 90% overall species identification. Three groups also compared both systems specifically for the identification of yeasts [20-22]. Our study is the first performed in Canada, and also the first to include all varieties of microorganisms such as bacteria, mycobacteria, yeast and filamentous fungi. We obtained comparable results in our study, taking into account the correct identification to species, genus and complex/group combined. The findings of our study demonstrate that Bruker Biotyper and VITEK MS perform comparably for identification when the microorganism is present in the database. Analysed separately, the rate of correct identification to species, genus and complex/group for each microorganism’s category is similar for both systems, except for mycobacteria, actinomycetes and filamentous fungi. Bruker Biotyper was found to be superior for the identification of filamentous fungi with the current manufacturer’s database, with more strains accounted for in Bruker database, and fewer misidentifications obtained. However, VITEK MS correctly identified more mycobacteria and aerobic actinomycetes to species level compared to genus level identification for Bruker Biotyper. Some authors previously suggested that the score for the correct identification to species level of 2 for Biotyper could be lowered to 1.9 [23] or to 1.7 [24]. In our study, if the cut off used for species identification was 1.7, the ratio of correct mycobacteria and actinomycetes identifications to species obtained with the Bruker Biotyper system would have been comparable to VITEK MS. However, a large number of mycobacteria and actinomycetes strains have not been tested with VITEK MS since the inactivation protocol provided by bioMérieux at the time of the study was not functional and the strains were still viable after processing. This could have influenced the accurate comparison of both systems since a large number of strains tested only with the Bruker Biotyper system gave no identification. bioMérieux has since released (in August 2013) a new protocol for the inactivation of mycobacteria and actinomycetes. Other groups have suggested that the score for the correct identification to species level of 2 could be also lowered for other microorganisms such as certain species of Staphylococcus, Streptococcus, Candida, and dermatophytes [25-27]. Our results do not support these findings since species identification of these three genera were excellent with the actual cut off value, excepted for filamentous fungi. As the LSPQ is the microbiology reference laboratory for the identification of microorganisms received from clinical laboratories in the province of Quebec, we possess a large collection of rare and unusual microorganisms. According to our knowledge, this study is the first to test the accuracy of identification of microorganisms not present in MALDI-TOF MS databases. For these microorganisms, the expected answer would have been no identification, or if a representative genus of the unknown strain was present, a correct identification to genus or complex/group. For this part of the study, VITEK MS gave significantly more misidentification than the Bruker Biotyper system. We recognize however that for more strains tested the name of the genus and / or species were not present in the VITEK MS IVD database compared to the Bruker database, since the RUO database was the only one available at the time of the study. This reflects the fact that the Bruker database contained more genus and species than the VITEK MS IVD database at the time of the evaluation. However, another database is available with the VITEK MS system (Saramis) which is an open database contained more species that the IVD database and which was not evaluated in this study. Consequently, the size and quality of the database are essential to accuracy and instrument performance. For Bruker Biotyper system, the four misidentifications to the genus level were four strains of Shigella identified as E. coli. The limitation of identification for some microorganisms are well known and transparently mentioned by the manufacturer. The only two other misidentifications by the Bruker Biotyper system were two strains of Mycobacterium goodii identified as Mycobacterium wolinskyi. This two species share similar biochemical and growth characteristics and are both closely related to M. smegmatis [28]. VITEK MS gave a worrying number of misidentifications when the microorganism was not in the database, particularly for Gram-positive cocci and rods, non-fermentative Gram-negative rods and filamentous fungi. Nearly half of the misidentifications were to the species level, the remaining misidentifications being most problematic, except for the Shigella strains which are a known limitation of the system. In addition, some misidentifications to the genus are from the opposite Gram stain, reinforcing the fact that Gram staining and morphology examination should still be maintained in an identification algorithm comprising MALDI-TOF MS. Six out of nine non tuberculous mycobacteria (NTM) were wrongly identified at the species or the genus level. The fact that 3 NTM were considered as members of the M. tuberculosis complex, even with low confidence, may poses a problem in patient management treatment. However, the protocol used at the time of the study could also have influenced these misidentifications. Misidentification of filamentous fungi with VITEK MS appears particularly problematic, with 12 misidentifications which were given an incorrect yeast genus. Authors in other MALDI-TOF MS evaluation studies have previously reported the use of a formic acid-based protein extraction using a bacterial lysis step or the use of formic acid directly on the bacterial smear before matrix application to be needed, mainly for Gram-positive bacteria. This was mainly reported in studies using the Bruker Biotyper system [29-33]. We observed that formic acid extraction methods, both on slide or in tube, were used significantly more to obtain accurate identification with the Bruker Biotyper system than the VITEK MS system. This is an important issue since repeating the identification with the formic acid extraction method, particularly with the in tube protocol, could delay the time of results. As shown by Dubois et al, the use of the VITEK MS system generated a low frequency of unusable spectra without formic acid use that is compatible and convenient for routine practice [34]. Deak et al. reported that Bruker Biotyper system was extremely sensitive to the amount of organism applied to the target plate, and over-application often resulted in low confidence scores or no identification, particularly for yeasts [35]. They also reported that in contrast, VITEK MS produces accurate results for yeast with high percent confidence levels for species identification done through formic acid extraction performed directly on the target plate. According to our experience, the use of a prior formic acid extraction step, otherwise than recommended by the manufacturer protocols, should be used with Gram-positive isolates with mucoid or dry textured colonies for MALDI TOF MS identification.

Conclusions

In conclusion, our study demonstrates that both systems gave a high level (above 85%) of correct identification for a wide range of microorganisms. However, VITEK MS gave more misidentification when the microorganism analysed was not present in the database, compared to Bruker Biotyper. This should be taken into account for the utilisation of this technology alone for microorganism identification in a public health laboratory, where isolates received are often difficult to identify and/or unusual microorganisms. Both systems allow the user to add his own spectra in order to build his own database (for VITEK MS it is in a separate database called SARAMIS). In a public health reference laboratory, validation of a species that increasing database content should allow to raise the identification power of MALDI-TOF MS.

Complete list of microorganism identification results when the microorganism is present in both databases.

(DOCX) Click here for additional data file.

Complete list of microorganism identification results when the microorganism is present only in the Bruker Biotyper database.

(DOCX) Click here for additional data file.

Complete list of microorganism identification results when the microorganism is present only in the VITEK MS IVD database.

(DOCX) Click here for additional data file.
  28 in total

1.  Comparison of the Bruker Biotyper and Vitek MS matrix-assisted laser desorption ionization-time of flight mass spectrometry systems for identification of mycobacteria using simplified protein extraction protocols.

Authors:  Cheryl A Mather; Sheila F Rivera; Susan M Butler-Wu
Journal:  J Clin Microbiol       Date:  2013-10-30       Impact factor: 5.948

2.  Improved performance of bacterium and yeast identification by a commercial matrix-assisted laser desorption ionization-time of flight mass spectrometry system in the clinical microbiology laboratory.

Authors:  John Haigh; Amarjeet Degun; Melvyn Eydmann; Michael Millar; Mark Wilks
Journal:  J Clin Microbiol       Date:  2011-07-06       Impact factor: 5.948

3.  Comparative evaluation of the Bruker Biotyper and Vitek MS matrix-assisted laser desorption ionization-time of flight (MALDI-TOF) mass spectrometry systems for identification of yeasts of medical importance.

Authors:  Nicasio Mancini; Elena De Carolis; Laura Infurnari; Antonietta Vella; Nicola Clementi; Luisa Vaccaro; Alberto Ruggeri; Brunella Posteraro; Roberto Burioni; Massimo Clementi; Maurizio Sanguinetti
Journal:  J Clin Microbiol       Date:  2013-05-15       Impact factor: 5.948

Review 4.  MALDI-TOF MS for the diagnosis of infectious diseases.

Authors:  Robin Patel
Journal:  Clin Chem       Date:  2014-10-02       Impact factor: 8.327

5.  Differentiation of Mycobacterium species by analysis of the heat-shock protein 65 gene (hsp65).

Authors:  Hong Kim; Sun-Hyun Kim; Tae-Sun Shim; Mi-Na Kim; Gill-Han Bai; Young-Gil Park; Sueng-Hyun Lee; Gue-Tae Chae; Chang-Yong Cha; Yoon-Hoh Kook; Bum-Joon Kim
Journal:  Int J Syst Evol Microbiol       Date:  2005-07       Impact factor: 2.747

6.  Streptococcus pseudoporcinus sp. nov., a novel species isolated from the genitourinary tract of women.

Authors:  Sadjia Bekal; Christiane Gaudreau; Robert A Laurence; Esther Simoneau; Lélia Raynal
Journal:  J Clin Microbiol       Date:  2006-07       Impact factor: 5.948

7.  Performance of matrix-assisted laser desorption ionization-time of flight mass spectrometry for identification of bacterial strains routinely isolated in a clinical microbiology laboratory.

Authors:  A Bizzini; C Durussel; J Bille; G Greub; G Prod'hom
Journal:  J Clin Microbiol       Date:  2010-03-10       Impact factor: 5.948

8.  High-throughput identification of bacteria and yeast by matrix-assisted laser desorption ionization-time of flight mass spectrometry in conventional medical microbiology laboratories.

Authors:  S Q van Veen; E C J Claas; Ed J Kuijper
Journal:  J Clin Microbiol       Date:  2010-01-06       Impact factor: 5.948

9.  Comparative phylogenies of Burkholderia, Ralstonia, Comamonas, Brevundimonas and related organisms derived from rpoB, gyrB and rrs gene sequences.

Authors:  Lineda Ait Tayeb; Martine Lefevre; Virginie Passet; Laure Diancourt; Sylvain Brisse; Patrick A D Grimont
Journal:  Res Microbiol       Date:  2007-12-24       Impact factor: 3.992

10.  Identification and phylogeny of ascomycetous yeasts from analysis of nuclear large subunit (26S) ribosomal DNA partial sequences.

Authors:  C P Kurtzman; C J Robnett
Journal:  Antonie Van Leeuwenhoek       Date:  1998-05       Impact factor: 2.271

View more
  40 in total

1.  Comparison of Saramis 4.12 and IVD 3.0 Vitek MS Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry for Identification of Mycobacteria from Solid and Liquid Culture Media.

Authors:  Caroline Leyer; Guillaume Gregorowicz; Faiza Mougari; Laurent Raskine; Emmanuelle Cambau; Dominique de Briel
Journal:  J Clin Microbiol       Date:  2017-04-19       Impact factor: 5.948

2.  Comparison of two matrix-assisted laser desorption ionization-time of flight mass spectrometry systems for the identification of clinical filamentous fungi.

Authors:  Yanfei Huang; Mingxin Zhang; Min Zhu; Mei Wang; Yufeng Sun; Haitong Gu; Jingjing Cao; Xue Li; Shaoya Zhang; Jinglin Wang; Xinxin Lu
Journal:  World J Microbiol Biotechnol       Date:  2017-06-12       Impact factor: 3.312

Review 3.  Identification of Molds by Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry.

Authors:  Maurizio Sanguinetti; Brunella Posteraro
Journal:  J Clin Microbiol       Date:  2016-11-02       Impact factor: 5.948

Review 4.  Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry for the Rapid Detection of Antimicrobial Resistance Mechanisms and Beyond.

Authors:  Marina Oviaño; Germán Bou
Journal:  Clin Microbiol Rev       Date:  2018-11-28       Impact factor: 26.132

5.  Typing and Characterization of Bacteria Using Bottom-up Tandem Mass Spectrometry Proteomics.

Authors:  Fredrik Boulund; Roger Karlsson; Lucia Gonzales-Siles; Anna Johnning; Nahid Karami; Omar Al-Bayati; Christina Åhrén; Edward R B Moore; Erik Kristiansson
Journal:  Mol Cell Proteomics       Date:  2017-04-18       Impact factor: 5.911

Review 6.  Rapid and robust MALDI-TOF MS techniques for microbial identification: a brief overview of their diverse applications.

Authors:  Kyoung-Soon Jang; Young Hwan Kim
Journal:  J Microbiol       Date:  2018-02-28       Impact factor: 3.422

7.  Matrix-assisted laser desorption/ionization time-of-flight mass spectrometric identification and antifungal susceptibility analysis of Candida species isolated from patients with invasive yeast infections in five university hospitals.

Authors:  Zhimin Hu; Juling Zhang; Zhongju Chen; Zhengjiang Jin; Pei Leng; Junying Zhou; Xiaofang Xie
Journal:  Braz J Microbiol       Date:  2018-12-04       Impact factor: 2.476

8.  Evaluation of Potential Probiotics Isolated from Human Milk and Colostrum.

Authors:  Quésia S Damaceno; Jaqueline P Souza; Jacques R Nicoli; Raquel L Paula; Gabriela B Assis; Henrique C Figueiredo; Vasco Azevedo; Flaviano S Martins
Journal:  Probiotics Antimicrob Proteins       Date:  2017-12       Impact factor: 4.609

9.  Misidentification of Risk Group 3/Security Sensitive Biological Agents by MALDI-TOF MS in Canada: November 2015-October 2017.

Authors:  D Pomerleau-Normandin; M Heisz; M Su
Journal:  Can Commun Dis Rep       Date:  2018-05-03

10.  How many human proteoforms are there?

Authors:  Ruedi Aebersold; Jeffrey N Agar; I Jonathan Amster; Mark S Baker; Carolyn R Bertozzi; Emily S Boja; Catherine E Costello; Benjamin F Cravatt; Catherine Fenselau; Benjamin A Garcia; Ying Ge; Jeremy Gunawardena; Ronald C Hendrickson; Paul J Hergenrother; Christian G Huber; Alexander R Ivanov; Ole N Jensen; Michael C Jewett; Neil L Kelleher; Laura L Kiessling; Nevan J Krogan; Martin R Larsen; Joseph A Loo; Rachel R Ogorzalek Loo; Emma Lundberg; Michael J MacCoss; Parag Mallick; Vamsi K Mootha; Milan Mrksich; Tom W Muir; Steven M Patrie; James J Pesavento; Sharon J Pitteri; Henry Rodriguez; Alan Saghatelian; Wendy Sandoval; Hartmut Schlüter; Salvatore Sechi; Sarah A Slavoff; Lloyd M Smith; Michael P Snyder; Paul M Thomas; Mathias Uhlén; Jennifer E Van Eyk; Marc Vidal; David R Walt; Forest M White; Evan R Williams; Therese Wohlschlager; Vicki H Wysocki; Nathan A Yates; Nicolas L Young; Bing Zhang
Journal:  Nat Chem Biol       Date:  2018-02-14       Impact factor: 15.040

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.